The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global ALK Positive Lung Cancer Treatment Market Research Report 2025

Global ALK Positive Lung Cancer Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1712230

No of Pages : 70

Ask Your Query
Synopsis
ALK positive lung cancer treatment treats people get lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene).

The global ALK Positive Lung Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for ALK Positive Lung Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Positive Lung Cancer Treatment.

Report Scope

The ALK Positive Lung Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ALK Positive Lung Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the ALK Positive Lung Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

F. Hoffmann-La Roche

Pfizer

Novartis

TP Therapeutics

Bristol-Myers Squibb

Eli Lilly and Company

Takeda

Beacon Pharma

Segment by Type

Crizotinib

Alectinib

Ceritinib

Brigatinib

Other

Segment by Application

Hospital

Clinics

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ALK Positive Lung Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Crizotinib

1.2.3 Alectinib

1.2.4 Ceritinib

1.2.5 Brigatinib

1.2.6 Other

1.3 Market by Application

1.3.1 Global ALK Positive Lung Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2019-2030)

2.2 ALK Positive Lung Cancer Treatment Growth Trends by Region

2.2.1 Global ALK Positive Lung Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 ALK Positive Lung Cancer Treatment Historic Market Size by Region (2019-2024)

2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2025-2030)

2.3 ALK Positive Lung Cancer Treatment Market Dynamics

2.3.1 ALK Positive Lung Cancer Treatment Industry Trends

2.3.2 ALK Positive Lung Cancer Treatment Market Drivers

2.3.3 ALK Positive Lung Cancer Treatment Market Challenges

2.3.4 ALK Positive Lung Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue

3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2019-2024)

3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2019-2024)

3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue

3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio

3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2023

3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served

3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service

3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 ALK Positive Lung Cancer Treatment Breakdown Data by Type

4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2019-2024)

4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2025-2030)

5 ALK Positive Lung Cancer Treatment Breakdown Data by Application

5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2019-2024)

5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America ALK Positive Lung Cancer Treatment Market Size (2019-2030)

6.2 North America ALK Positive Lung Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)

6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2019-2030)

7.2 Europe ALK Positive Lung Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)

7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2019-2030)

8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2019-2030)

9.2 Latin America ALK Positive Lung Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)

9.4 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2019-2030)

10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche

11.1.1 F. Hoffmann-La Roche Company Detail

11.1.2 F. Hoffmann-La Roche Business Overview

11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction

11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.1.5 F. Hoffmann-La Roche Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction

11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction

11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 TP Therapeutics

11.4.1 TP Therapeutics Company Detail

11.4.2 TP Therapeutics Business Overview

11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction

11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.4.5 TP Therapeutics Recent Development

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Detail

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction

11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.5.5 Bristol-Myers Squibb Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Detail

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction

11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.6.5 Eli Lilly and Company Recent Development

11.7 Takeda

11.7.1 Takeda Company Detail

11.7.2 Takeda Business Overview

11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction

11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.7.5 Takeda Recent Development

11.8 Beacon Pharma

11.8.1 Beacon Pharma Company Detail

11.8.2 Beacon Pharma Business Overview

11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction

11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024)

11.8.5 Beacon Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Crizotinib

Table 3. Key Players of Alectinib

Table 4. Key Players of Ceritinib

Table 5. Key Players of Brigatinib

Table 6. Key Players of Other

Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Region (2019-2024)

Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Region (2025-2030)

Table 13. ALK Positive Lung Cancer Treatment Market Trends

Table 14. ALK Positive Lung Cancer Treatment Market Drivers

Table 15. ALK Positive Lung Cancer Treatment Market Challenges

Table 16. ALK Positive Lung Cancer Treatment Market Restraints

Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2019-2024)

Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2023)

Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service

Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global ALK Positive Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. F. Hoffmann-La Roche Company Detail

Table 50. F. Hoffmann-La Roche Business Overview

Table 51. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product

Table 52. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 53. F. Hoffmann-La Roche Recent Development

Table 54. Pfizer Company Detail

Table 55. Pfizer Business Overview

Table 56. Pfizer ALK Positive Lung Cancer Treatment Product

Table 57. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 58. Pfizer Recent Development

Table 59. Novartis Company Detail

Table 60. Novartis Business Overview

Table 61. Novartis ALK Positive Lung Cancer Treatment Product

Table 62. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 63. Novartis Recent Development

Table 64. TP Therapeutics Company Detail

Table 65. TP Therapeutics Business Overview

Table 66. TP Therapeutics ALK Positive Lung Cancer Treatment Product

Table 67. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 68. TP Therapeutics Recent Development

Table 69. Bristol-Myers Squibb Company Detail

Table 70. Bristol-Myers Squibb Business Overview

Table 71. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product

Table 72. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 73. Bristol-Myers Squibb Recent Development

Table 74. Eli Lilly and Company Company Detail

Table 75. Eli Lilly and Company Business Overview

Table 76. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product

Table 77. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 78. Eli Lilly and Company Recent Development

Table 79. Takeda Company Detail

Table 80. Takeda Business Overview

Table 81. Takeda ALK Positive Lung Cancer Treatment Product

Table 82. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 83. Takeda Recent Development

Table 84. Beacon Pharma Company Detail

Table 85. Beacon Pharma Business Overview

Table 86. Beacon Pharma ALK Positive Lung Cancer Treatment Product

Table 87. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2019-2024) & (US$ Million)

Table 88. Beacon Pharma Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

List of Figures

Figure 1. Global ALK Positive Lung Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2023 VS 2030

Figure 3. Crizotinib Features

Figure 4. Alectinib Features

Figure 5. Ceritinib Features

Figure 6. Brigatinib Features

Figure 7. Other Features

Figure 8. Global ALK Positive Lung Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Clinics Case Studies

Figure 12. Other Case Studies

Figure 13. ALK Positive Lung Cancer Treatment Report Years Considered

Figure 14. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2023

Figure 18. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2023

Figure 20. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)

Figure 22. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)

Figure 26. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2019-2030)

Figure 34. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)

Figure 42. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2019-2030)

Figure 46. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 49. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 51. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 53. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 54. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 55. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock